Home
 News
 Web resources

 Tumours list
   Contribution



Projects

RARE UROLOGIC TUMOURS
   General information
   Urologic tumour list
     Contribution

RARE MELANOMA
   General information
   Rare melanoma list
     Contribution

RARE SKIN TUMOURS
   General information
   Skin tumor list
     Contribution

RARE BREAST CANCER

(GLS - italian project)
   Info generali
   Scheda dati

HINT-OUT
   General information
   Design
   System
   Objectives
   Registration
   Member area

 

partially supported by



News

07/01/2004 - Gene associated with higher risk of melanoma in men

Researchers have known that genetic factors play a role in the development of malignant melanoma, a form of skin cancer. It has also been known that men have a 1 in 58 chance of developing the disease in their lifetimes, while women have a 1 in 82 chance. Researchers from the University Hospital in Tuebingen studied blood samples of 450 healthy volunteers and 500 people with malignant melanoma. They found a gene, BRAF, with variations present in the people with melanoma. These variations, though, seemed to confer a higher risk of disease only for men. This might help explain why men have a higher risk of developing malignant melanoma. Read the article, freely available on BioMed Central.

News Archive

3/8/2001 WHY?
17/11/2001 W.H.O. Collaborating Centre for Cancer Control of Uncommon Tumours
10/12/2001 On November 30th, in the hall of the S. Pio X Private Hospital of Milan, Italy, the
18/12/2001 Post-meeting survey
3/12/2002 QUIZ
5/5/2002 Dear Colleagues,Notebook Veri Kurtarma
29/01/2003 New publication on rare cancers !
28/07/2003 Thyroid Cancer Treatment Receives Orphan Drug Status
02/08/2003 Breast cancer in men Kiralık Ofis Ankara
24/09/2003 GISTs: The revolution continues
28/10/2003 Lessons learned from the management of a rare genetic cancer.
17/11/2003 Successful photodynamic therapy for nonresectable cholangiocarcinoma.
08/03/2004 Susceptibility to Common Adult Cancers in Retinoblastoma Survivors
29/03/2004 FDA Approves First Drug for mesothelioma
25/08/2004 Gene therapy cures malignant melanoma in mice
20/10/2004 FDA grants orphan drug status to two new anticancer drugs.
15/11/2004 New experimental drug for myeloproliferative disorder
20/01/2005 New leukemia treatment granted FDA orphan drug status.
28/02/2005 U.S. F.D.A. grants new orphan drug designation for a targeted therapeutic for head and neck cancer.
02/05/2005 Possible targets for a multiple myeloma vaccine
17/10/2005 Orphan drug troxacitabine approved for AML in EU
03/11/2005 FDA designes interleukin 21 as an orphan drug
01/12/2005 Zactima has received FDA orphan drug designation
25/01/2006 CETT Program for Rare Genetic Diseases
23/02/2006 New research studies of multiple myeloma